Portfolio company
Neurovision
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company provides diagnostic blood tests and retinal imaging software to help healthcare providers detect and monitor neurodegenerative diseases.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
neuroClues
This company develops portable eye-tracking medical devices and AI software for clinicians to identify neurological disorders through ocular biomarkers.
Optina Diagnostics
This company develops artificial intelligence platforms and hyperspectral retinal imaging cameras to help eye specialists diagnose and manage retinal and neurodegenerative diseases.
GLX Analytix
This company develops blood-based diagnostic and monitoring tests for clinicians to manage neurodegenerative, autoimmune and neuropsychiatric diseases using glycocalyx biomarkers and artificial intelligence.
Neurotrack
Neurotrack develops digital cognitive assessment tools and health programmes for healthcare providers and pharmaceutical companies to detect and manage Alzheimer's disease.
NeuraLight
The company develops an artificial intelligence platform measuring eye movements to create digital biomarkers for pharmaceutical companies and researchers treating neurological disorders.
Digital Diagnostics
This digital health company provides autonomous AI diagnostic software to healthcare providers for detecting diabetic retinopathy and eye diseases at the point of care.
Siloam Vision
This company develops AI-enabled retinal imaging systems and diagnostic software for healthcare providers to detect preventable blindness in neonates and adults.
Circular Genomics
This company develops circular RNA blood tests for diagnosing neurological and psychiatric disorders for healthcare providers, researchers and pharmaceutical organisations.
